| Liver-related deaths in persons infected with the human immunodeficiency virus: the D: A: D study S Collins, T Mertenskoetter, E Loeliger, R Tressler, I Weller, N Friis-Møller, ... Archives of internal medicine 166 (15), 1632-1641, 2006 | 1275 | 2006 |
| Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D: A: D study: a multi-cohort collaboration D: A: D Study Group The Lancet 371 (9622), 1417-1426, 2008 | 958 | 2008 |
| Once-daily dolutegravir versus raltegravir in antiretroviral-naive adults with HIV-1 infection: 48 week results from the randomised, double-blind, non-inferiority SPRING-2 study F Raffi, A Rachlis, HJ Stellbrink, WD Hardy, C Torti, C Orkin, M Bloch, ... The Lancet 381 (9868), 735-743, 2013 | 438 | 2013 |
| Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a … L Wittkop, HF Günthard, F De Wolf, D Dunn, A Cozzi-Lepri, A De Luca, ... The Lancet infectious diseases 11 (5), 363-371, 2011 | 358 | 2011 |
| Predictors of trend in CD4-positive T-cell count and mortality among HIV-1-infected individuals with virological failure to all three antiretroviral-drug classes B Ledergerber, PLATO collaboration The Lancet 364 (9428), 51-62, 2004 | 354 | 2004 |
| Risk factors and outcomes for late presentation for HIV-positive persons in Europe: results from the Collaboration of Observational HIV Epidemiological Research Europe Study … A Mocroft, JD Lundgren, ML Sabin, AA Monforte, N Brockmeyer, ... PLoS medicine 10 (9), e1001510, 2013 | 272 | 2013 |
| Natural history of chronic hepatitis B in co-infected patients M Puoti, C Torti, R Bruno, G Filice, G Carosi Journal of hepatology 44, S65-S70, 2006 | 271 | 2006 |
| Dolutegravir in antiretroviral-experienced patients with raltegravir-and/or elvitegravir-resistant HIV-1: 24-week results of the phase III VIKING-3 study A Castagna, F Maggiolo, G Penco, D Wright, A Mills, R Grossberg, ... The Journal of infectious diseases 210 (3), 354-362, 2014 | 252 | 2014 |
| Incidence of tuberculosis among HIV-infected patients receiving highly active antiretroviral therapy in Europe and North America Antiretroviral Therapy Cohort Collaboration Clinical Infectious Diseases 41 (12), 1772-1782, 2005 | 238 | 2005 |
| Response to combination antiretroviral therapy: variation by age Collaboration of Observational HIV Epidemiological Research Europe (COHERE ... Aids 22 (12), 1463-1473, 2008 | 226 | 2008 |
| All-cause mortality in treated HIV-infected adults with CD4 ≥500/mm3 compared with the general population: evidence from a large European observational cohort … Collaboration of Observational HIV Epidemiological Research Europe (COHERE ... International journal of epidemiology 41 (2), 433-445, 2011 | 220 | 2011 |
| Early impairment of gut function and gut flora supporting a role for alteration of gastrointestinal mucosa in human immunodeficiency virus pathogenesis A Gori, C Tincati, G Rizzardini, C Torti, T Quirino, M Haarman, KB Amor, ... Journal of clinical microbiology 46 (2), 757-758, 2008 | 214 | 2008 |
| Specific prebiotics modulate gut microbiota and immune activation in HAART-naive HIV-infected adults: results of the “COPA” pilot randomized trial A Gori, G Rizzardini, B Van't Land, KB Amor, J Van Schaik, C Torti, ... Mucosal immunology 4 (5), 554, 2011 | 148 | 2011 |
| Severe hepatotoxicity during combination antiretroviral treatment: incidence, liver histology, and outcome M Puoti, C Torti, D Ripamonti, F Castelli, S Zaltron, B Zanini, A Spinetti, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 32 (3), 259-267, 2003 | 142 | 2003 |
| Prevalence and distribution of soil‐transmitted helminth (STH) infections in urban and indigenous schoolchildren in Ortigueira, State of Paranà, Brasil: implications for control C Scolari, C Torti, A Beltrame, A Matteelli, F Castelli, M Gulletta, M Ribas, ... Tropical Medicine & International Health 5 (4), 302-307, 2000 | 113 | 2000 |
| Long-term mortality in HIV-positive individuals virally suppressed for> 3 years with incomplete CD4 recovery FN Engsig, R Zangerle, O Katsarou, F Dabis, P Reiss, J Gill, K Porter, ... Clinical infectious diseases 58 (9), 1312-1321, 2014 | 111 | 2014 |
| CD4 cell count and the risk of AIDS or death in HIV-Infected adults on combination antiretroviral therapy with a suppressed viral load: a longitudinal cohort study from COHERE Opportunistic Infections Project Team of the Collaboration of Observational ... PLoS medicine 9 (3), e1001194, 2012 | 110 | 2012 |
| Risk of triple-class virological failure in children with HIV: a retrospective cohort study Pursuing Later Treatment Options II (PLATO II) project team for the ... The Lancet 377 (9777), 1580-1587, 2011 | 100 | 2011 |
| Anti program death-1/anti program death-ligand 1 in digestive cancers E de Guillebon, P Roussille, E Frouin, D Tougeron World journal of gastrointestinal oncology 7 (8), 95, 2015 | 98* | 2015 |
| Genetic Differentiation, Gene Flow and the Origin of Infestations of the Medfly, Ceratitis Capitata G Gasperi, M Bonizzoni, LM Gomulski, V Murelli, C Torti, AR Malacrida, ... Genetica 116 (1), 125-135, 2002 | 98 | 2002 |
Massimo PuotiDirettore, SC Malattie Infettive. AO Ospedale Niguarda Ca' GrandaVerified email at ospedaleniguarda.it
